6-Shogaol IV Therapy

Clinical studies demonstrate that 6-Shogoal has incredible anti-cancer, anti-oxidative, and anti-inflammatory actions. Furthermore, 6-Shogaol has been shown to protect dopaminergic neurons in Parkinson’s disease models via anti-neuroinflammation.

Recent studies suggest ginger-derived substances affect not only diabetes, asthma, metabolic syndrome and cancer but also hold anti-inflammatory potential. Research has proven that 6-shogaol can significantly reduce hallmarks of inflammation, such as leukocyte infiltration or oedema formation, and exhibit neuroprotective effects.

A case history of seven patients diagnosed with rheumatoid arthritis (males and females, aged 50–67 years) revealed that the use of ginger esulted in pain relief, improved joint agility, and less stiffness, which goes to show how anti-inflammatory 6-Shogoal truly is.

Within cancer, 6-Shogaol is a potent inhibitor of MDA-MB-231 cell invasion, and the molecular mechanism involves at least in part the down-regulation of MMP-9 transcription by targeting the NF-κB activation cascade. This class of naturally occurring small molecules thus have the potential for clinical use as antimetastatic treatments.

In summary, 6-Shogaol prevents cancer cells from growing into healthy tissue by blocking genes responsible for the spread of cancer. Both local growth and spread by metastasis are inhibited. 6-Shogaol reactivates self-destruction in cancer cells, thereby preventing tumor growth. 6-Shogaol has also proved beneficial in promoting central nervous system health.